Peptide Therapy: Where Do We Go From Here?

Peptide therapies have moved from niche biohacking circles into mainstream medicine, reshaping conversations around weight management, metabolic health, and men's health. As demand accelerates and new compounds enter the market, patients and providers alike are asking: what does responsible, evidence-based peptide therapy actually look like, and where is the field headed next?

This conversation will bring together perspectives from pharmacy, obesity medicine, and urology to examine how peptide therapy is being used today, what the science does and doesn't yet support, and how patients can navigate an increasingly crowded and fast-moving landscape.

We'll cover:

• The current state of peptide therapy and where the science is heading
• How peptides are being used in weight management and metabolic care
• The role of peptides in men's health and urological care
• Navigating safety, sourcing, and quality in a rapidly growing market
• What patients should know before starting peptide therapy
• Where regulation, access, and innovation are likely to collide next

Panelists:

• Shaun Noorian, Founder & CEO, Empower Pharmacy
• Dr. Rekha Kumar, Senior Medical Advisor, Found
• Dr. Alex Tatem, Corporate Director of Men’s Health, U.S. Urology
• Christina Farr, CEO, Second Opinion; GP, Scrub Capital